Search research articles
Contact Us
Filters
Showing results (61-70 of 103) with videos related to
Page
of 11
Sort By:
Iscience
|
July 31, 2025
Age- and sex-associated differences in immune cell populations
Reza Gheitasi, Sabine Baumgart, Daniela Roell, et al.
Frontiers in Immunology
|
January 30, 2023
Persistent humoral and CD4<sup>+</sup> T<sub>H</sub> cell immunity after mild SARS-COV-2 infection-The CoNAN long-term study
Clara Schnizer, Nico Andreas, Wolfgang Vivas, et al.
Iscience
|
July 10, 2024
Increased peritoneal B1-like cells during acute phase of human septic peritonitis
Christian von Loeffelholz, René Winkler, Cynthia Weigel, et al.
Archives of Biochemistry and Biophysics
|
August 15, 2019
Labile heme impairs hepatic microcirculation and promotes hepatic injury
Franziska A Englert, Raphael A Seidel, Kerstin Galler, et al.
Intensive Care Medicine
|
April 7, 2026
Measuring signatures of host resistance, disease tolerance, and damage in human sepsis: a prospective cohort study
Arnab Chowdhury, Rachel E Powell, Jason N Kennedy, et al.
Frontiers in Immunology
|
December 18, 2018
<i>Candida albicans</i> β-Glucan Differentiates Human Monocytes Into a Specific Subset of Macrophages
Julia Leonhardt, Silke Große, Christian Marx, et al.
Cells
|
February 25, 2022
Small Extracellular Vesicles from Peripheral Blood of Aged Mice Pass the Blood-Brain Barrier and Induce Glial Cell Activation
Diana M Morales-Prieto, José M Murrieta-Coxca, Milan Stojiljkovic, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 20, 2020
CXCL5-mediated recruitment of neutrophils into the peritoneal cavity of <i>Gdf15</i>-deficient mice protects against abdominal sepsis
Isa Santos, Henrique G Colaço, Ana Neves-Costa, et al.
Cell
|
June 17, 2017
Metabolic Adaptation Establishes Disease Tolerance to Sepsis
Sebastian Weis, Ana Rita Carlos, Maria Raquel Moita, et al.
BMJ Open
|
April 23, 2024
Epirubicin for the Treatment of Sepsis and Septic Shock (EPOS-1): study protocol for a randomised, placebo-controlled phase IIa dose-escalation trial
Daniel Thomas-Rüddel, Michael Bauer, Luís Ferreira Moita, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 103) with videos related to
Sort By:
Page
of 11
Iscience
|
July 31, 2025
Age- and sex-associated differences in immune cell populations
Reza Gheitasi, Sabine Baumgart, Daniela Roell, et al.
Frontiers in Immunology
|
January 30, 2023
Persistent humoral and CD4<sup>+</sup> T<sub>H</sub> cell immunity after mild SARS-COV-2 infection-The CoNAN long-term study
Clara Schnizer, Nico Andreas, Wolfgang Vivas, et al.
Iscience
|
July 10, 2024
Increased peritoneal B1-like cells during acute phase of human septic peritonitis
Christian von Loeffelholz, René Winkler, Cynthia Weigel, et al.
Archives of Biochemistry and Biophysics
|
August 15, 2019
Labile heme impairs hepatic microcirculation and promotes hepatic injury
Franziska A Englert, Raphael A Seidel, Kerstin Galler, et al.
Intensive Care Medicine
|
April 7, 2026
Measuring signatures of host resistance, disease tolerance, and damage in human sepsis: a prospective cohort study
Arnab Chowdhury, Rachel E Powell, Jason N Kennedy, et al.
Frontiers in Immunology
|
December 18, 2018
<i>Candida albicans</i> β-Glucan Differentiates Human Monocytes Into a Specific Subset of Macrophages
Julia Leonhardt, Silke Große, Christian Marx, et al.
Cells
|
February 25, 2022
Small Extracellular Vesicles from Peripheral Blood of Aged Mice Pass the Blood-Brain Barrier and Induce Glial Cell Activation
Diana M Morales-Prieto, José M Murrieta-Coxca, Milan Stojiljkovic, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 20, 2020
CXCL5-mediated recruitment of neutrophils into the peritoneal cavity of <i>Gdf15</i>-deficient mice protects against abdominal sepsis
Isa Santos, Henrique G Colaço, Ana Neves-Costa, et al.
Cell
|
June 17, 2017
Metabolic Adaptation Establishes Disease Tolerance to Sepsis
Sebastian Weis, Ana Rita Carlos, Maria Raquel Moita, et al.
BMJ Open
|
April 23, 2024
Epirubicin for the Treatment of Sepsis and Septic Shock (EPOS-1): study protocol for a randomised, placebo-controlled phase IIa dose-escalation trial
Daniel Thomas-Rüddel, Michael Bauer, Luís Ferreira Moita, et al.
Page
of 11